Baker McKenzie has provided sophisticated legal advice and services to many of the world's most dynamic and global organizations since our founding in 1949. With a network of more than 4,200+ locally qualified, internationally experienced lawyers in 77 offices worldwide and 47 countries, Baker McKenzie has the knowledge and resources to deliver the broad scope of quality legal services required to respond effectively to international and local needs -- consistently, confidently, and with sensitivity for cultural, social, and legal practice differences.
Baker McKenzie’s 10,000+ lawyers, supporting professionals, and staff are citizens of more than 60 countries. Baker McKenzie’s professionals are admitted to practice in nearly 250 jurisdictions and have been educated at more than 1,200 institutions, including nearly all of the world's leading law schools.
Founded in 1981, Analysis Group is one of the largest economics consulting firms, with more than 850 professionals across 14 offices in North America, Europe, and Asia. An important differentiator for our clients – including top law firms, Fortune Global 500 companies, and government agencies – is our ability to combine a strong team of advanced-degree professionals with highly credentialed affiliated experts from academia, government, and industry. Together, we provide expertise across a wide range of practice areas, such as antitrust, intellectual property, transfer pricing, general commercial litigation, and strategy. Additionally, we have worked on a number of high-profile litigations. We are able to provide assistance in all stages of the litigation process, including preparation of expert reports, assistance with rebutting other experts, pre-trial discovery, and deposition and trial preparation. Analysis Group is ranked as one of the top economics firms in the world by the Global Competition Review. We have also appeared in the Boston Globe's "Top Places to Work” in Massachusetts rankings for the past ten years, and have been named to the annual Top 100 Women-Led Businesses in Massachusetts list by the Boston Globe Magazine and Commonwealth Institute for the past five years.
For more information, visit our website at www.analysisgroup.com
Dr. Tien specializes in transfer pricing and applied economics with an emphasis on issues relating to intangibles and licensing. His practice is technology and IP-based with a practical eye toward managing global transfer pricing. Before joining Baker McKenzie, Dr. Tien was an economist at PwC where he helped taxpayers develop their multinational pricing policies and resolve U.S. and non-U.S. audits.
Dr. White specializes in health care, transfer pricing and valuation, health economics and outcomes research (HEOR), and commercial damages. He combines his expertise in applied microeconomics, statistics, and econometrics with nearly 20 years of experience in industry-specific client engagements.
A diverse range of clients have retained Dr. White to assist in all stages of the litigation cycle – from advising on discovery issues to testifying at trial. He has worked on general commercial business litigation matters such as allegations of false advertising and breach of contract, investigations into alleged off-label promotion of prescription drugs, and the economic impact of generic entry/substitution. He has also analyzed economic issues relevant to class certification and quantification of damages. Dr. White has managed numerous commercial litigation matters, supporting academic and industry specialists with expertise in industrial organization, statistics, health economics, and marketing. His tax and transfer pricing work has evaluated the arm’s length nature of pricing in intercompany transactions, and the estimation of useful economic lives for various tangible and intangible assets.
In addition to his litigation work, Dr. White has worked on the development of empirical models for determining factors that may help identify patients at risk of prescription opioid abuse, as well as the estimation of societal economic costs of prescription opioid abuse. His research and numerous publications have focused on specific health economics issues, including the costs of abuse and the evaluation of the impact of various FDA-approved abuse-deterrent opioids. He has presented at, and participated in, a number of panel discussions at industry conferences.
Dr. White also serves as an adjunct faculty member in the Northeastern University’s Department of Economics, where he teaches courses on applied microeconomics and applied econometrics.